Revlimid Trademark Details

Revlimid was registered on Tuesday, March 28, 2006 and is currently owned by Celgene Corporation under the registration number 3074309 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 9 years ago on Wednesday, April 15, 2015, according to the United State Patent & Trademark Office
Word Mark Revlimid
Status Alive Registered 800 — Registered and Renewed

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 78290583
Registration Number 3074309
Status Date Wednesday, April 15, 2015
Filing Date Wednesday, April 15, 2015
Registration Date Tuesday, March 28, 2006
Attorney Camille M. Miller

Correspondent

Camille M. Miller
COZEN O'CONNOR
One Liberty Place
1650 MARKET ST
PHILADELPHIA PA 19103

Case File Statements

Goods & Services Pharmaceutical Preparations, Namely, Cytokine Inhibitory Drugs; Pharmaceutical Preparations That Modulate the Immune System

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, September 2, 2003
First Use Anywhere Thursday, February 19, 2004
First Use In Commerce Thursday, June 3, 2004
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.